We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Memory Loss in Alzheimer’s Disease Linked to Both Amyloid Plaques and Tau Tangles

By LabMedica International staff writers
Posted on 31 Dec 2019
A team of neurodegenerative disease researchers has linked the APOE-epsilon-4 gene to increased formation of toxic tau protein aggregates (tangles) as well as amyloid-beta plaques in individuals with Alzheimer’s disease (AD).

Apolipoprotein E-epsilon-4 is the single most important genetic risk factor for Alzheimer disease. More...
While APOE-epsilon-4 has been shown to be associated with increased amyloid-beta burden, its association with cerebral tau pathology has been controversial.

In the current study, investigators at McGill University (Montreal, Canada) sought to determine whether APOE-epsilon-4 was associated with medial temporal tau pathology independently of other AD risk factors such as amyloid-beta, sex, clinical status, and age. The investigators worked with two cohorts of Alzheimer’s disease patients, which comprised 489 participants, selected based on availability of amyloid-PET, tau-PET, magnetic resonance imaging, and genotyping for APOE-epsilon-4.

The mean (SD) age of the 489 participants was 70.5 (7.1) years; 171 were APOE-epsilon-4 carriers (34.9%), and 230 of 489 were men. In both cohorts, APOE-epsilon-4 was associated in increased tau-PET uptake in the entorhinal cortex and hippocampus independently of amyloid-beta, sex, age, and clinical status.

These results indicated that the elevated risk of developing dementia conferred by APOE-epsilon-4 genotype involved mechanisms associated with both amyloid-beta and tau aggregation.

"Alzheimer's disease is defined by the aggregation of two proteins in the brain: amyloid plaques and tau tangles, both of which are known to be neurotoxic," said first author Joseph Therriault, a doctoral student in neuroscience at McGill University. "APOE-epsilon-4 has been associated with amyloid plaques, but its association with tau tangles has been controversial. In our study of nearly 500 individuals, we demonstrate this association in living humans. For years, we have known that people with the APOE-epsilon-4 gene have more memory problems. We were able to show that carriers of this gene also had greater levels of tau tangles in memory centers of the brain, even after controlling for how much amyloid plaques they had."

The study was published in the December 20, 2019, online edition of the Journal of the American Medical Association: Neurology.

Related Links:
McGill University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Platelet Function Analyzer
PL-12
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The method combines ultrasonic and fluorescence techniques to track amyloid aggregation in real time (Image Credit: Shutterstock)

Blood Test Measures Amyloid Seeding Activity to Detect Alzheimer’s Disease

Early, accurate diagnosis of Alzheimer’s disease (AD) remains challenging in routine practice, despite its role as the leading cause of dementia worldwide. Confirmation typically relies on cerebrospinal... Read more

Pathology

view channel
Image: TRUECAM automatically eliminates ambiguous or uninformative regions in whole-slide pathology images, enhancing the reliability of diagnostic analysis. (Photo courtesy of PolyU)

AI-Pathologist Framework Improves Accuracy and Reliability in Cancer Diagnosis

Ensuring reliable cancer diagnosis from digital pathology remains a critical challenge as clinical decisions rely on accurate slide interpretation. While artificial intelligence (AI) has accelerated whole-slide... Read more

Industry

view channel
Image: HealthTab will distribute the Abbott Afinion 2 Analyzer to NHS-linked pharmacies for hemoglobin A1c (HbA1c) and lipid profile testing. (Photo courtesy of Abbott)

New Collaboration Expands Point-of-Care Testing Across UK Community Pharmacies

HealthTab, a wholly owned subsidiary of Avricore Health, has entered a formal collaboration agreement with Abbott to supply and distribute Abbott’s point-of-care testing products in the UK through the... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.